Amplia Therapeutics Limited Stock
Stocks
ATX
AU0000023822
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
01:10:11 2026-10-30 am EDT
|
5-day change | 1st Jan Change | ||
| 0.0840 AUD | -5.62% |
|
+5.00% | -44.00% |
| Market Cap | 43.12M 30.34M 27.17M 24.99M 22.64M 42.33M 2.88B 298M 120M 1.52B 114M 111M 4.78B | P/E 2027 * |
-3.65x | P/E 2028 * | -12x |
|---|---|---|---|---|---|
| Enterprise Value | 25.22M 17.74M 15.89M 14.62M 13.24M 24.75M 1.68B 174M 69.97M 886M 66.58M 65.17M 2.79B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | 2.08x |
| Free-Float |
90.48% | Yield 2027 * |
-
| Yield 2028 * | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| ATX | Delayed | |
OTC Markets
| INNMF | Delayed |
| 1 day | -5.62% | ||
| 1 week | +5.00% | ||
| 1 month | -26.96% | ||
| 3 months | -35.38% | ||
| 6 months | -44.00% | ||
| Current year | -44.00% |
| 1 week | 0.08 |  | 0.09 |
| 1 month | 0.08 | | 0.12 |
| Current year | 0.08 | | 0.28 |
| 1 year | 0.08 | | 0.28 |
| 3 years | 0.05 | | 0.42 |
| 5 years | 0.05 | | 0.42 |
| 10 years | 0.04 | | 18.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2022-12-04 | |
Hamish George
DFI | Director of Finance/CFO | - | 2021-09-30 |
Jason Lickliter
CTO | Chief Tech/Sci/R&D Officer | - | 2025-05-11 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Peach
BRD | Director/Board Member | 70 | 2015-09-01 |
Warwick Tong
CHM | Chairman | - | 2018-05-24 |
Jane Bell
CHM | Chairman | - | 2026-06-29 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/8/25 | Exercice | Chairman | 750,000 | 0.1933% | ||
| 9/8/25 | Free | Founder | 447,000 | 0.1152% | ||
| 9/8/25 | Exercice | Director | 535,000 | 0.1379% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.62% | +5.00% | -40.00% | -1.18% | 30.34M | |
| -0.62% | -1.87% | +42.87% | +64.15% | 63.77B | |
| +0.35% | +3.20% | +14.40% | +81.76% | 56.37B | |
| +0.53% | +1.96% | +16.24% | +103.35% | 54.62B | |
| -2.81% | -4.31% | +23.50% | +47.83% | 44.06B | |
| -0.33% | -1.93% | +19.28% | +98.80% | 42.11B | |
| +0.55% | +2.31% | +225.14% | +866.21% | 41B | |
| +3.27% | +47.96% | +112.84% | +96.58% | 34.92B | |
| +1.22% | -1.44% | +14.57% | +46.95% | 32.82B | |
| +0.89% | +20.55% | -40.62% | +349.24% | 24.7B | |
| Average | -0.26% | +7.29% | +38.82% | +175.37% | 39.44B | |
| Weighted average by Cap. | +0.18% | +5.44% | +47.99% | +176.66% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | 9.5M 6.68M 5.99M 5.51M 4.99M 9.33M 635M 65.66M 26.36M 334M 25.08M 24.55M 1.05B |
| Net income | -11.6M -8.16M -7.31M -6.72M -6.09M -11.39M -775M -80.17M -32.18M -408M -30.63M -29.98M -1.29B | -4.1M -2.88M -2.58M -2.38M -2.15M -4.02M -274M -28.34M -11.38M -144M -10.83M -10.59M -454M |
| Net Debt | -17.9M -12.59M -11.28M -10.37M -9.4M -17.57M -1.2B -124M -49.66M -629M -47.26M -46.26M -1.98B | -23.4M -16.46M -14.74M -13.56M -12.29M -22.97M -1.56B -162M -64.92M -822M -61.78M -60.47M -2.59B |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-30 | A$0.0840 | -5.62% | 1,154,303 |
| 26-10-29 | A$0.0890 | +7.23% | 602,933 |
| 26-10-28 | A$0.0830 | +5.06% | 339,346 |
| 26-10-27 | A$0.0790 | +1.28% | 315,976 |
| 26-10-26 | A$0.0780 | -2.50% | 269,970 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0840AUD
Average target price
0.4200AUD
Spread / Average Target
+400.00%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATX Stock
Select your edition
All financial news and data tailored to specific country editions
